Device Vascular

Hi-Torque Advance

Payments companies reported to CMS as associated with Hi-Torque Advance. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4,151associated payments (2023-2025)
19clinicians with associated payments
1company reporting

By year

2023 $798
2024 $7.90
2025 $3,345

Payments reported as associated with Hi-Torque Advance, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular Surgery $3,275
Cardiovascular Disease $596
Interventional Cardiology $156
Physical Medicine & Rehabilitation $80.34
Vascular & Interventional Radiology $30.63
Thoracic Surgery (Cardiothoracic Vascular Surgery) $12.77

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Hi-Torque Advance

These are the largest totals companies reported as associated with Hi-Torque Advance. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Juan Carlos Correa Leawood, KS Vascular Surgery $3,250.00
Jeffrey Leavy Haddon Heights, NJ Cardiovascular Disease $160.69
Kartik Giri Haddon Heights, NJ Cardiovascular Disease $80.35
Scott Fertels Haddon Heights, NJ Cardiovascular Disease $80.35
Gregg Fortino Haddon Heights, NJ Cardiovascular Disease $80.35
Steven Silver Haddon Heights, NJ Cardiovascular Disease $80.34
Adam Levine Haddon Heights, NJ Interventional Cardiology $80.34
Daniel Tarditi Haddon Heights, NJ Cardiovascular Disease $80.34
Vijay Verma Colorado Springs, CO Physical Medicine & Rehabilitation $80.34
Michael Lalezarian Los Angeles, CA Vascular & Interventional Radiology $30.63

Prescribed Hi-Torque Advance?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.